Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
3.
Anaesthesia ; 70(7): 859-76, 2015 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-25950621

RESUMO

Guidelines are presented for the organisational and clinical peri-operative management of anaesthesia and surgery for patients who are obese, along with a summary of the problems that obesity may cause peri-operatively. The advice presented is based on previously published advice, clinical studies and expert opinion.


Assuntos
Anestesia , Obesidade , Assistência Perioperatória , Feminino , Humanos , Masculino , Anestesia/métodos , Anestesiologia , Medicina Bariátrica , Irlanda , Obesidade/cirurgia , Assistência Perioperatória/métodos , Sociedades Médicas , Reino Unido
5.
Int J Oral Maxillofac Surg ; 37(4): 384-5, 2008 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18262764

RESUMO

Placement of nasogastric tubes (NGTs) for feeding and gastric decompression is common in major head and neck surgical cases, surgical wards and intensive care units, and rarely results in complications. Knotting of an NGT occurs infrequently with small-bore feeding tubes. This report shows that this can occur even with large-bore feeding tubes. Risk factors and ways to avoid this in both awake and anaesthetized patients are discussed. A novel way of removing a knotted NGT is presented.


Assuntos
Remoção de Dispositivo/métodos , Intubação Gastrointestinal/efeitos adversos , Idoso de 80 Anos ou mais , Humanos , Masculino
7.
Br J Anaesth ; 92(6): 821-6, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15064244

RESUMO

BACKGROUND: Patients with systemic sepsis develop a capillary leak syndrome, and serum -albumin concentration decreases. Hyperoncotic albumin infusion can be used for volume expansion in these patients, but the degree and duration of effect are not well described. We assessed volume expansion by albumin 20% infusion and compared the retention of infused albumin in septic patients and healthy controls. METHODS: We gave albumin 20%, 200 ml as a rapid infusion to 70 patients with septic shock and 26 controls. Blood samples were taken before and 1, 5, 15, 30, 60, 120 and 240 min after the infusion for measurement of serum albumin concentration and haematocrit. Haemodilution and the percentage of administered albumin remaining intravascularly at each time were calculated. RESULTS: The mean proportion of the increase in albumin remaining at 4 h was 68.5 (sd 10)% in septic patients and 79 (5)% in controls (P<0.001). The albumin 20%, 200 ml caused a secondary fluid resorption and volume expansion maximal at 30 min, equivalent to a 430 ml infusion in septic patients and 500 ml in controls. CONCLUSIONS: After giving albumin, serum albumin concentrations decrease significantly faster in septic patients than in healthy controls.


Assuntos
Albuminas/farmacocinética , Substitutos do Plasma/farmacocinética , Albumina Sérica/metabolismo , Choque Séptico/terapia , Adulto , Idoso , Idoso de 80 Anos ou mais , Síndrome de Vazamento Capilar/sangue , Síndrome de Vazamento Capilar/etiologia , Pressão Venosa Central , Hematócrito , Hemodiluição , Humanos , Pessoa de Meia-Idade , Choque Séptico/sangue , Choque Séptico/complicações
9.
Anaesthesia ; 53(8): 789-803, 1998 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-9797524

RESUMO

A decrease in serum albumin concentrations is an almost inevitable finding in disease states, and is primarily mediated in the acute phase by alterations in vascular permeability and redistribution. This change is not disease specific but marked changes that persist are generally associated with a poorer prognosis. Critical appraisal of long-standing practices and the availability of alternative colloid solutions have led to a reduction in albumin replacement therapy, and a widespread tolerance of lower albumin concentrations in patients. The factors determining serum albumin concentrations, their measurement and the implications of hypoalbuminaemia are reviewed. The clinical value of serum albumin measurement is discussed.


Assuntos
Albumina Sérica/fisiologia , Reação de Fase Aguda/sangue , Albuminas/uso terapêutico , Biomarcadores/sangue , Coagulação Sanguínea/fisiologia , Permeabilidade da Membrana Celular/fisiologia , Feminino , Humanos , Pressão Osmótica , Complicações Pós-Operatórias/sangue , Pré-Eclâmpsia/sangue , Gravidez , Albumina Sérica/metabolismo , Inanição/sangue
10.
Clin Sci (Lond) ; 95(4): 459-65, 1998 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-9748422

RESUMO

1. Albumin is often administered intravenously to critically ill patients as a volume expander, to combat hypoalbuminaemia, and to decrease hyperbilirubinaemia. There is, however, an ongoing debate concerning the therapeutic benefit of the former which is an expensive form of treatment.2. Albumin has several biological functions, in particular as a ligand binder. It also acts as an extracellular transition metal ion-binding and radical-scavenging antioxidant. These functions are influenced by the presence of an exposed thiol group (cys 34) on the surface of the albumin molecule. 3. The ability of infused albumin to influence the plasma thiol pool, and hence antioxidant potential, was investigated in patients with sepsis syndrome.4. Plasma thiol levels rose rapidly after albumin infusion and remained elevated even after plasma albumin levels had declined significantly, due to interstitial leakage. Data are suggestive of some form of thiol exchange in the plasma of these patients between albumin and molecules containing oxidized thiol groups.5. Administration of albumin to patients with sepsis syndrome leads to a sustained increase in plasma thiols. Thiols have several important antioxidant functions, and thiol repletion in these patients, who are known to suffer from oxidative stress, may have beneficial antioxidant effects. Antioxidant repletion may represent an important facet of clinically administered albumin.


Assuntos
Albuminas/administração & dosagem , Antioxidantes/análise , Substitutos do Plasma/administração & dosagem , Compostos de Sulfidrila/sangue , Síndrome de Resposta Inflamatória Sistêmica/sangue , Síndrome de Resposta Inflamatória Sistêmica/terapia , Adulto , Idoso , Idoso de 80 Anos ou mais , Albuminas/análise , Estudos de Casos e Controles , Humanos , Infusões Intravenosas , Pessoa de Meia-Idade , Peso Molecular
11.
Intensive Care Med ; 23(6): 635-9, 1997 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-9255642

RESUMO

OBJECTIVE: To assess plasma iron status in critically ill patients with septic shock. DESIGN: Observational, prospective study. SETTING: Adult intensive care units in teaching and tertiary referral hospitals. PATIENTS AND PARTICIPANTS: Fifteen adult patients with established septic shock. Normal control subjects (n = 10) were also investigated. Data from patients and controls were compared with previously published iron values in critical care patients. MEASUREMENTS AND RESULTS: The indices investigated and correlated with clinical scores of illness severity included bleomycin-detectable iron, non-haem iron; transferrin and its percentage iron saturation, and the iron binding (anti-oxidant) activity of transferrin. Bleomycin-detectable iron was not present in the plasma of patients with septic shock whilst the plasma transferrin remained unsaturated with iron. One patient in multi-organ failure displayed bleomycin-detectable iron in plasma (1.16 mumol/l) and had 100% iron-saturation of transferrin. The plasma non-haem iron levels (7.84 +/- 1.82 mumol/l) were the lowest of all critical care patient groups studied by us. The plasma transferrin levels were also low but resulted in a near normal percentage saturation of transferrin with iron (34.6 +/- 6.5%). The scores of clinical severity correlated with changes in plasma iron chemistry. CONCLUSIONS: Patients with septic shock rarely have iron saturated transferrin in their plasma leading to the presence of bleomycin-detectable iron.


Assuntos
Ferro/sangue , Choque Séptico/sangue , APACHE , Adulto , Biomarcadores/sangue , Bleomicina/sangue , Estudos de Casos e Controles , Feminino , Humanos , Unidades de Terapia Intensiva , Quelantes de Ferro , Análise dos Mínimos Quadrados , Masculino , Pessoa de Meia-Idade , Insuficiência de Múltiplos Órgãos/sangue , Estudos Prospectivos , Estatísticas não Paramétricas
12.
Anaesthesia ; 52(4): 336-40, 1997 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-9135185

RESUMO

Rocuronium is a recently introduced nondepolarising neuromuscular blocking agent with a rapid onset and intermediate duration of action. Experimental observations have suggested that during onset it acts synergistically with other nondepolarising agents, but that at a steady state the combined action is additive. In order to investigate whether synergism during onset produces a clinical benefit we performed the following study of tracheal intubation conditions. Consenting patients presenting for elective surgery which required tracheal intubation were randomly allocated to receive a standard anaesthetic and either a twice ED95 dose of rocuronium, or vecuronium, or an equipotent mixture of both drugs. Tracheal intubation conditions were assessed after 60 s and scored as excellent, good, poor or impossible. The conditions produced in the rocuronium and the mixture groups were similar and both were significantly better than those of vecuronium. Excellent intubation conditions were achieved in 57% of the rocuronium group, 70% of the mixture group and 27% of the vecuronium group. We conclude that a mixture of rocuronium and vecuronium acts synergistically during the early part of their action and a mixture containing one ED95 of both agents provides comparable conditions for tracheal intubation as an equipotent dose of rocuronium.


Assuntos
Androstanóis , Intubação Intratraqueal , Bloqueio Neuromuscular , Fármacos Neuromusculares não Despolarizantes , Brometo de Vecurônio , Adulto , Idoso , Método Duplo-Cego , Combinação de Medicamentos , Sinergismo Farmacológico , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Junção Neuromuscular/efeitos dos fármacos , Rocurônio
13.
Anaesthesia ; 50(9): 804-6, 1995 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-7573873

RESUMO

A case of amniotic fluid embolus is described with an acute onset occurring 90 min after surgical delivery in a mildly pre-eclamptic primigravida undergoing Caesarean section for a breech presentation. Severe disseminated intravascular coagulation and massive postpartum haemorrhage were corrected and she went on to make a full recovery. The pathophysiology of amniotic fluid embolism is discussed and new diagnostic tests are reviewed. It is suggested that in this patient an amniotic fluid collection in dilated uterine veins was mobilised as venous tone returned following the offset of spinal anaesthesia and sympathetic blockade.


Assuntos
Anestesia Obstétrica , Raquianestesia , Cesárea , Embolia Amniótica/etiologia , Complicações Pós-Operatórias , Adulto , Embolia Amniótica/diagnóstico , Feminino , Humanos , Período Pós-Operatório , Gravidez , Transtornos Puerperais/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...